siRNA therapy lowers triglycerides in patients with rare ailment

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran lessened triglyceride levels through 80% and decreased the risk of pancreatitis in people with chronic chylomicronemia, along with or without a hereditary medical diagnosis.